Ingenuity safeguards pet health, collaboration creates the future | Federal Animal Health and Zhongr

2025-11-16

On November 15th, Federal Animal Health and Zhongrui Supply Chain officially signed a strategic cooperation agreement in Zhuhai. The two parties focused on the core track of pet pharmaceuticals and finalized all - round in - depth cooperation from product supply to channel empowerment. They will build a new ecological synergy in the industry through resource complementarity, injecting strong impetus into the high - quality development of the "pet economy".

· A Glimpse of the Meeting

As a wholly - owned subsidiary of the Federal Pharmaceutical Group, Federal Animal Health relies on the parent company's more than 30 - year accumulation in human medicine R & D and production, and has transferred pharmaceutical - grade standards to the pet health field. It has now established three modern production bases in Guangdong, Inner Mongolia, and Henan. Its products cover more than 100 varieties in all dosage forms such as powders, injections, and oral liquids, constructing a product matrix that runs through the entire scenarios of "prevention - treatment - maintenance" for pets, and strengthening the safety defense line of pet medicine with professional standards.

· The Three Factories of Federal Animal Health

As the "ecological hub" of the pet industry, Zhongrui Supply Chain has rich experience in channel layout, market operation, and B - end service empowerment. Currently, the company has established a mature market network in Beijing, Tianjin, Shanghai, Hangzhou, Shenzhen and other places, and plans to achieve full national coverage next year. With a mature supply - chain service system, Zhongrui Supply Chain precisely connects high - quality products with terminal scenarios such as pet hospitals and pet stores, providing full - link support from logistics distribution to market promotion. In this cooperation, Zhongrui Supply Chain will fully leverage its channel network advantages to help Federal Animal Health's pet pharmaceuticals quickly reach national terminals, and at the same time, use terminal demand to feed back product R & D optimization to achieve precise matching of supply and demand.

In the future, the two parties will deepen cooperation around three core directions. Federal Animal Health will continue to provide high - quality pet pharmaceuticals, adhering to the bottom line of product safety and effectiveness. Zhongrui Supply Chain will accelerate the national channel layout, build an efficient warehousing, logistics, and terminal service system, and improve product market coverage and delivery efficiency. The two parties will take "joint construction" as the core, jointly promote the expansion of domestic and overseas markets, and jointly promote the standardized development of the pet pharmaceutical industry, enabling more pet owners to enjoy authoritative and safe pet health solutions.

· Group Photo at the Signing Ceremony


This strategic cooperation is a precise match between Federal Animal Health's high - quality product strength and Zhongrui Supply Chain's professional channel strength. As the pet - owning population upgrades from "keeping pets alive" to "raising pets well", the demand for the professionalism and safety of pet pharmaceuticals continues to rise. The resource integration of the two parties not only achieves complementary advantages but also sets a new paradigm for industry cooperation of "product R & D + supply - chain empowerment + global layout", which will promote the pet pharmaceutical industry to move steadily towards a more standardized, efficient, and internationally competitive direction.

· Group Photo for Souvenir

Photo | Zhuhai Federal Animal Health

Text | Federal Animal Health Division

Review | Group Brand and Culture Department


share
Write a Review...